Fox Business
Biogen Alzheimer's data disappoints, Lilly gets slight bump
Reuters
Disappointing data for Biogen Inc's experimental Alzheimer's drug dragged shares of the company lower on Wednesday, while investors took a slightly more positive view of new findings for a treatment from Eli Lilly and Co. Shares of Biogen traded 3.9 ...
Reuters
Disappointing data for Biogen Inc's experimental Alzheimer's drug dragged shares of the company lower on Wednesday, while investors took a slightly more positive view of new findings for a treatment from Eli Lilly and Co. Shares of Biogen traded 3.9 ...